Status:
COMPLETED
Validation of Bulbicam Used on Patient Suffering From Diabetes Without Retinopathy
Lead Sponsor:
Meddoc
Conditions:
Diabetes
Eligibility:
All Genders
18-80 years
Brief Summary
\- The study consists of the following two study populations: 1) Patients suffering from diabetes without retinopathy of both genders with various durations of disease 2) Age-matched healthy control (...
Detailed Description
* The study consists of the following two study populations: 1) Patients suffering from diabetes without retinopathy of both genders with various durations of disease 2) Age-matched healthy control (H...
Eligibility Criteria
Inclusion
- Consists of patients diagnosed with Diabetes without retinopathy of both gender; passed the age of 18 years without any other eye disease; suffering from other know serious disease.
- but have a health situation in accordance with expectations related to the age.
- Gender- and age-matched controls to patients in, passed the age of 18 years without any eye diseases; not suffering from other know serious disease and have a health situation in accordance with expectations related to the age.
Exclusion
- Other visual disturbances and blindness
- Posterior Chamber Intra Ocular Lens (PCIOL)
- Physical or psychiatric disease, which may disturb the measuring procedure
- Patients who are not able to perform eye movements, so no full paresis of any ocular muscles.
- Patients whose visual acuity is less more than 1 logMAR in any eye, as these will not be able to focus on the test stimuli.
- Patients whose visible part of the eye is abnormal, such as subconjunctival hemorrhages or deformed pupils.
- Patients whose pupils are not able to respond normally to dilation or contraction due to damaged nerves, mechanical damage of the pupil etc.
- Participating in another clinical trial with pharmaceuticals the last six weeks before start of this trial treatment.
- With known alcoholic and drug dependency
- Not able to understand information.
- Not willing to give written consent to participate in the study.
Key Trial Info
Start Date :
June 3 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 16 2025
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT06973694
Start Date
June 3 2024
End Date
April 16 2025
Last Update
May 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oslo University Hospital
Oslo, Norway, 0450